While the mortality rate has declined compared to most population groups over the past thirty-five years, cancers of the lung and bronchus are still the leading cause of cancer death among both men and women in the United States. According to American Cancer Society estimates, approximately 226,650 new cases of lung and bronchus cancer and 124,730 deaths are expected to be reported in the year 2025. The high mortality rate is due largely to the fact that a majority of these cancers are not detected until the disease has reached an advanced stage. At this stage, treatment is less effective. Lung cancer became an early focus of the Specialized Programs of Research Excellence (SPORE) program due to the huge burden in terms of morbidity and mortality. The first three Lung SPOREs were funded in 1992. Besides P50 grants, the list of Lung Cancer SPOREs includes three P20 planning cancer health disparities SPORE grants that focus on lung cancer.
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
